The Role of the CD40 Antigen on Malignant B Cells

References

• Banchereau J., Bazan F., Blanchard D., Brière F., Galizzi J.P., Van Kooten C., Liu Y.J., Rousset F., Saeland S. The CD40 antigen and its ligand. Annual Review of Immunology 1994; 12: 881–922
   PubMed Web of Science ®Google Scholar
• McLennan I. C. M. Germinal Centers. Annual Review of Immunology 1994; 12: 117–139
   PubMed Web of Science ®Google Scholar
• Van den Eertwegh A. J. M., Noelle R.J., Roy M., Shepherd D.M., Aruffo A., Ledbetter J.A., Boersma W. J. A., Claassen E. In vivo CD40-gp39 interactions are essential forthymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions. J Exp. Med. 1993; 178: 1555–1565
   PubMed Web of Science ®Google Scholar
• Foy T.M., Shepherd D.M., Durie F.H., Aruffo A., Ledbetter J.A., Noelle R.J. In vivo CD40-gp39 interactions are essential for thymus- dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J. Exp. Med. 1993; 178: 1567–1575
   PubMed Web of Science ®Google Scholar
• Blanchard D., Gaillard C., Hermann P., Banchereau J. Role of CD40 antigen and interleukin-2 in T cell-dependent human B lymphocyte growth. Eur. J. Immunol 1994; 24: 330–335
   PubMed Web of Science ®Google Scholar
• Lederman S., Yellin M.J., Cleary A.M., Pernis A., Inghirami G., Cohn L.E., Covey L.R., Lee J.J., Rothman P., Chess L. T-BAM/CD40-L on helper T lymphocytes augments lym-phokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death. J. Immunol 1994; 152: 2163–2171
   PubMed Web of Science ®Google Scholar
• Spriggs M.K., Armitage R.J., Strockbine L., Clifford K.N., Macduff B.M., Sato T.A., Maliszewski C.R., Fanslow W.C. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J. Exp. Med. 1992; 176: 1543–1550
   PubMed Web of Science ®Google Scholar
• Nishioka Y., Lipsky P.E. The role of CD40-CD40 lig-and interaction in human T cell-B cell collaboration. J. Immunol. 1994; 153: 1027–1036
   PubMed Web of Science ®Google Scholar
• Aruffo A., Farrington M., Hollenbaugh D., Li X., Milatovich A., Nonoyama S., Bajorath J., Grosmaire L.S., Stenkamp R., Neubauer M., Roberts R.L., Noelle R.J., Ledbetter J.A., Francke U., Ochs H.D. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 1993; 72: 291–300
   PubMed Web of Science ®Google Scholar
• Ledbetter J.A., Shu G., Gallagher M., Clark E.A. Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDw40). J. Immunol. 1987; 138: 788–794
   PubMed Web of Science ®Google Scholar
• Banchereau J., Rousset F. Growing human B lymphocytes in the CD40 system. Nature 1991; 353: 678–679
   PubMed Web of Science ®Google Scholar
• Banchereau J., de Paoli P., Valle A., Garcia E., Rousset F. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 1991; 251: 70–72
   PubMed Web of Science ®Google Scholar
• Fluckiger A.C., Rossi J.F., Bussel A., Bryon P., Banchereau J., Defrance T. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors. Blood 1992; 80: 3173–3181
   PubMed Web of Science ®Google Scholar
• Crawford D.H., Catovsky D. In vitro activation of leukaemic B cells by interleukin-4 and antibodies to CD40. Immunology 1993; 80: 40–44
   PubMed Web of Science ®Google Scholar
• Kluin-Nelemans J.C., Beverstock G.C., Mollevanger P., Wessels H.W., Hoogendoorn E., Willemze R., Falkenburg J. H. F. Proliferation and cytogenetic analysis of hairy cell leukemia upon stimulation via the CD40 antigen. Blood 1994; 84: 3134–3141
   PubMed Web of Science ®Google Scholar
• Stamenkovic I., Clark E.A., Seed B. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO. 1989; 8: 1403–1410
   PubMed Web of Science ®Google Scholar
• Gruss H.-J., Dower S.K. Tumor necrosis factor ligand superfamily: Involvement in the pathology of malignant lym-phomas. Blood 1995; 85: 3378–3404
   PubMed Web of Science ®Google Scholar
• Holder M.J., Wang H., Milner A.E., Casamayor M., Armitage R., Spriggs M.K., Fanslow W.C., Maclennan I. C. M., Gregory C.D., Gordon J. Suppression of apoptosis in normal and neoplasiic human B lymphocytes by CD40 ligand is independent of Bcl-2 induction. Eur. J. Immunol. 1993; 23: 2368–2371
   PubMed Web of Science ®Google Scholar
• Watanabe-Fukunaga R., Brannan C.I., Copeland N.G., Jenkins N.A., Nagata D. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356: 314–316
   PubMed Web of Science ®Google Scholar
• Inui S., Kaisho T., Stamenkovic I., Seed B., Clark E.A., Kishimoto T. Identification of the intracytoplasmic region essential for signal transduction through a B cell activation molecule, CD40. Eur. J. Immunol 1990; 20: 1747–1753
   PubMed Web of Science ®Google Scholar
• Uckun F.M., Schieven G.L., Dibirdik I., Chandan-Langlie M., Tuel-Ahlgren L., Ledbetter J.A. Stimulation of protein tyrosine phosphorylation, phosphionositide turnover, and multiple previously unidentified serine/threonine-specific protein kinases by the pan-B-cell receptor CD40/Bp50 at discrete developmental stages of human B-cell ontogeny. J. Biol. Chem. 1991; 26: 17478–17485
   Google Scholar
• Hu H.M., O'Rourke K., Boguski M.S., Dixit V.M. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 1994; 269: 30069–30072
   PubMed Web of Science ®Google Scholar
• Berberich I., Shu G.L., Clark E.A. Cross-linking CD40 on B cells rapidly activates nuclear factor-kappaB. J. Immunol 1994; 153: 4357–4366
   PubMed Web of Science ®Google Scholar
• Ling N.R., Maclennan I. C. M., Mason D.Y. B-cell and plasma cell antigens: new and previously defined clusters. Leucocyte typing 111. White cell differentiation antigens, A.J. McMichael. Oxford University Press, Oxford, New York, Tokyo 1987; 302–335
   Google Scholar
• Uckun F.M. Regulation of human B-cell ontogeny. Blood 1990; 76: 1908–1923
   PubMed Web of Science ®Google Scholar
• Uckun F.M., Gajl-Peczalska K., Myers D.E., Jaszcz W., Haissig S., Ledbetter J.A. Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lin-eage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells. Blood 1990; 76: 2449–2456
   PubMed Web of Science ®Google Scholar
• Alderson M.R., Armitage R.J., Tough T.W., Strockbine L., Fanslow W.C., Spriggs M.K. CD40 expression by human monocytes: Regulation by cytokines and activation of mono-cytes by the ligand for CD40. Exp. Med. 1993; 178: 669–674
   PubMed Web of Science ®Google Scholar
• Caux C., Massacrier C., Vanbervliet B., Dubois B., Van Kooten C., Durand I., Banchereau J. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 1994; 180: 1263–1272
   PubMed Web of Science ®Google Scholar
• Saeland S., Duvert B., Caux C., Pandrau D., Favre C., Valle A., Durand I., Charbord P., de Vries J.E., Banchereau J. Distribution of surface-membrane molecules on bone marrow and cord blood CD34+ hematopoietic cells. Exp. Hematol 1992; 20: 24–33
   PubMed Web of Science ®Google Scholar
• Galy A., Spits H. CD40 is functionally expressed on human thymic epithelial cells. J Immunol 1992; 149: 775–782
   PubMed Web of Science ®Google Scholar
• Karmann K., Hughes C. C. W., Schechner J., Fanslow W.C., Pober J.S. CD40 on human endothelial cells: Inducibility by cytokines and functional regulation of adhesion molecule expression. Proceedings of the National Academy of Sciences, USA 1995; 92: 4342–4346
   PubMed Web of Science ®Google Scholar
• Paulie S., Rosen A., Ehlin-Henriksson B., Braesh-Anderson S., Jakobson E., Koho H., Perlman P. The human B lymphocyte and carcinoma antigen, CDw40, is a phospho-protein involved in growth signal transduction. J. Immunol 1989; 142: 590
   PubMed Web of Science ®Google Scholar
• Carbone A., Gloghini A., Gattei V., Aldinucci D., Degan M., de Paoli P., Zagonel B., Pinto A. Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines. Blood 1995; 85: 780–789
   PubMed Web of Science ®Google Scholar
• Dijkstra N.H., Planken E.V., Bakkus M., Willemze R., Kluin-Nelemans J.C. Proliferation of precursor B-ALL by triggering the CD40 antigen. Blood 1995; 86, (suppll)
   Web of Science ®Google Scholar
• Castle B.E., Kishimoto K., Stearns C., Brown M.L., Kehry M.R. Regulation of expression of the ligand for CD40 on T helper lymphocytes. J. Immunol 1993; 151: 1777–1788
   PubMed Web of Science ®Google Scholar
• Casamayor-Palleja M., Khan M., Maclennan I. C. M. A subset of CD4+ memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex. J. Exp. Med. 1995; 181: 1293–1301
   PubMed Web of Science ®Google Scholar
• Foy T.M., Laman J.D., Ledbetter J.A., Aruffo A., Claassen E., Noelle R.J. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med. 1994; 180: 157–163
   PubMed Web of Science ®Google Scholar
• Ranheim E.A., Kipps T.J. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 1993; 177: 925–935
   PubMed Web of Science ®Google Scholar
• Yellin M.J., Sippel K., Inghirami G., Covey L.R., Lee J.J., Sinning J., Clark E.A., Chess L., Lederman S. CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L: Potential role in regulating helper effector function. J. Immunol 1994; 152: 598–608
   PubMed Web of Science ®Google Scholar
• Van Kooten C., Gaillard C., Galizzi J.-P., Hermann P., Fossiez F., Banchereau J., Blanchard D. B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40. Eur. J. Immunol. 1994; 24: 787–792
   PubMed Web of Science ®Google Scholar
• Caux C., Burdin N., Galibert L., Hermann P., Renard N., Servet-Delprat C., Banchereau J. Functional CD40 on B lymphocytes and dendritic cells. Res. Immunol 1994; 145: 235–239
   PubMedGoogle Scholar
• Allen R.C., Armitage R.J., Conley M.E., Rosenblatt H., Jenkins N.A., Copeland N.G., Bedell M.A., Edelhoff S., Disteche C.M., Simoneaux D.K., Fanslow W.C., Belmont J., Spriggs M.K. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 1993; 259: 990–993
   PubMed Web of Science ®Google Scholar
• Callard R.E., Armitage R.J., Fanslow W.C., Spriggs M.K. CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunology Today 1993; 14: 559–564
   PubMedGoogle Scholar
• Farrington M., Grosmaire L.S., Nonoyama S., Fischer S.H., Hollenbaugh D., Ledbetter J.A., Noelle R.J., Aruffo A., Ochs H.D. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proceedings of the National Academy of Sciences, USA 1994; 91: 1099–1103
   PubMed Web of Science ®Google Scholar
• Gordon J., Millsum M.J., Guy G.R., Ledbetter J.A. Resting B lymphocytes can be triggered directly through the CDw40 (Bp50) antigen. J. Immunol 1988; 140: 1425–1430
   PubMed Web of Science ®Google Scholar
• Arpin C., Dechanet J., Van Kooten C., Merville P., Grouard G., Briere F., Banchereau J., Liu Y.-J. Generation of memory B cells and plasma cells in vitro. Science 1995; 268: 720–722
   PubMed Web of Science ®Google Scholar
• Barrett T.B., Shu G., Clark E.A. CD40 signaling activates CDlla/CD18 (LFA-l)-mediated adhesion in B cells. J. Immunol 1991; 146: 1722–1729
   PubMed Web of Science ®Google Scholar
• Clark E.A., Shu G. Association between IL-6 and CD40 signalling. IL-6 induces phosphorylation of CD40 receptors. J Immunol 1990; 145: 1400–1406
   PubMed Web of Science ®Google Scholar
• Burdin N., Van Kooten C., Galibert L., Abrams J.S., Wijdenes J., Banchereau J., Rousset F. Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes. J. Immunol 1995; 154: 2533–2544
   PubMed Web of Science ®Google Scholar
• Saeland S., Duvert V., Moreau I., Banchereau J. Human B cell precursors proliferate and express CD23 after CD40 ligation. J Exp. Med 1993; 178: 113–120
   PubMed Web of Science ®Google Scholar
• Renard N., Duvert V., Blanchard D., Banchereau J., Saeland S. Activated CD4+ T cells induce CD40-dependent proliferation of human B cell precursors. J. Immunol 1994; 152: 1693–1701
   PubMed Web of Science ®Google Scholar
• Larson A.W., LeBien T.W. Cross-linking CD40 on human B cell precursors inhibits or enhances growth depending on the stage of development and the IL costimulus. J. Immunol 1994; 153: 584–594
   PubMed Web of Science ®Google Scholar
• Defrance T., Vanbervliet B., Briere F., Durand I., Rousset F., Banchereau J. Interleukin 10 and transforming growth factor β cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J. Exp. Med. 1992; 671–682
   PubMed Web of Science ®Google Scholar
• Defrance T., Fluckiger A.-C., Rossi J.-F., Rousset F., Banchereau J. In vitro activation of B-CLL cells. Leak. Lymph. 1991; 5: 13–19, Suppl.
   PubMed Web of Science ®Google Scholar
• Planken E.V., Dijkstra N., Willemze R., Kluin-Nelemans J.C. Proliferation of B cell malignancies in all stages of differentiation upon stimulation in the “CD40 system”. 1995, submitted
   Google Scholar
• Lotz M., Ranheim E., Kipps T.J. Transforming growth factor P as endogenous growth inhibitor of chronic lymphocytic leukemia B cells. J. Exp. Med. 1994; 179: 999–1004
   PubMed Web of Science ®Google Scholar
• Johnson P. W. M., Watt S.M., Betts D.R., Davies D., Jordan S., Norton A.J., Lister T.A. Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/stromal cell system. Blood 1993; 82: 1848–1857
   PubMed Web of Science ®Google Scholar
• Kishimoto T. The biology of interleukin-6. Blood 1989; 74: 1–10
   PubMed Web of Science ®Google Scholar
• Pellat-Deceunynck C., Bataille R., Robillard N., Harousseau J.-L., Rapp M.-J., Juge-Morineau N., Wijdenes J., Amiot M. Expression of CD28 and CD40 in human myeloma cells: A comparative study with normal plasma cells. Blood 1994; 84: 2597–2603
   PubMed Web of Science ®Google Scholar
• Kozbor D., Moretta A., Messner H.A., Moretta L., Croce C.M. Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasmacells. J Immunol. 1987; 138: 4128–4132
   PubMed Web of Science ®Google Scholar
• Planken E.V., Falkenburg J. H. F., Willemze R., Kluin-Nelemans J.C. Proliferation of malignant B cells in the CD40 system. Br. J. Haematol. 1994; 87(suppl. 1)232, (abstract)
   Google Scholar
• Westendorf J.J., Ahmann G.J., Armitage R.J., Spriggs M.K., Lust J.A., Greipp P.R., Katzmann J.A., Jelinek D.F. CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line. J. Immunol. 1994; 152: 117–127
   PubMed Web of Science ®Google Scholar
• Tong A.W., Zhang B., Mues G., Solano M., Hanson T., Stone M.J. Anti-CD40 antibody binding modulates human multiple myeloma clonogenicity in vitro. Blood 1994; 84: 3026–3033
   PubMed Web of Science ®Google Scholar